跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-ATORVASTATIN TABLET 20 MG - HSA Drug Approval Details
Approvals
/
HSA
/
APO-ATORVASTATIN TABLET 20 MG
Approved
THERAPEUTIC
APO-ATORVASTATIN TABLET 20 MG
APOTEX INC. - CANADAAPOTEX INC. (ETOBICOKE SITE) (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Sep 5, 2013
Approval ID
cf99f1f97e200607
Company
APOTEX INC. - CANADAAPOTEX INC. (ETOBICOKE SITE) (CANADA)
Type
Therapeutic
Approval Details
Approval Id
cf99f1f97e200607
Drug Name
APO-ATORVASTATIN TABLET 20 MG
Product Name
APO-ATORVASTATIN TABLET 20 MG
Approval Number
SIN14403P
Approval Date
2013-09-05
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
C10AA05
Atc Item Name
atorvastatin
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE 22MG EQV ATORVASTATIN
20 MG
ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE 22MG EQV ATORVASTATIN
20 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 5, 2013
Approval ID
cf99f1f97e200607
Type
Therapeutic
Back to HSA Approvals